Table 4 |
|||||
|
FCGR3A and FCGR2A genotypes in rheumatoid factor positive and negative RA patients |
|||||
| Polymorphism |
Genotype |
RA RF+ (n = 130) |
RA RF- (n = 57) |
P (χ2) |
OR (95% CI) |
|
|
|||||
| FCGR3A-158 |
FF |
66 (50.8%) |
30(52.6%) |
0.82 |
0.93 (0.50–1.73) |
| FV/VV |
64(49.2%) |
27 (47.4%) |
|||
| FCGR2A-131 |
HH |
103 (79.2%) |
42(73.7%) |
0.4 |
1.36 (0.66–2.82) |
| HR/RR |
27 (20.8%) |
15 (26.3%) |
|||
|
|
|||||
|
P values are given for RA RF+ versus RA RF- using a 2×2 contingency table. CI, 95% confidence interval; OR, odds ratio; RA, rheumatoid arthritis; RF, rheumatoid factor. |
|||||
|
Matsumoto et al. Arthritis Research & Therapy 2005 7:R1183 doi:10.1186/ar1802 |
|||||
